Società Emmaus Life Sciences, Inc. Other OTC
Azioni
EMMA
US29137T1016
Biotecnologia
Attività
Vendite per attività
USD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 21 | 100,0 % | 18 | 100,0 % | -10,77% |
Vendite per regione
USD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 21 | 100,0 % | 18 | 100,0 % | -10,77% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
George Sekulich
PSD | President | 59 | 01/05/19 |
Willis Lee
CHM | Chairman | 64 | 17/07/19 |
Yasushi Nagasaki
DFI | Director of Finance/CFO | 57 | 01/05/11 |
Mark Diamond
CIO | Chief Investment Officer | - | - |
Charles Stark
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/01/13 |
Lan T. Tran
ADM | Chief Administrative Officer | 48 | 17/07/19 |
Dale E. Short
SEC | Corporate Secretary | - | 01/09/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Wei Peu Zen
BRD | Director/Board Member | 71 | 17/07/19 |
Willis Lee
CHM | Chairman | 64 | 17/07/19 |
Ian Zwicker
BRD | Director/Board Member | 77 | 17/07/19 |
George Sekulich
PSD | President | 59 | 01/05/19 |
Seah LIm
BRD | Director/Board Member | 66 | 04/10/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 53 637 554 | 25 870 168 ( 48,23 %) | 0 | 48,23 % |
Coordinate società
Emmaus Life Sciences, Inc.
21250 Hawthorne Boulevard Suite 800
90503, Torrance
+
http://www.emmausmedical.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+23,13% | 52,73 Mrd | |
+37,49% | 39 Mrd | |
-8,73% | 38,52 Mrd | |
+28,09% | 30,38 Mrd | |
-12,26% | 26,39 Mrd | |
+10,57% | 26,08 Mrd | |
+45,05% | 14,15 Mrd | |
+32,23% | 12,6 Mrd | |
-6,56% | 11,51 Mrd |